Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. - Wikidata - awgldk - TriplyDB

Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.

Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.

http://www.wikidata.org/entity/Q34021856

about

Recent advances in understanding psoriasis Immunology of psoriasis Putting together the psoriasis puzzle: an update on developing targeted therapies Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA).Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study.Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.The pathophysiological role of dendritic cell subsets in psoriasis.Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease Resolved psoriasis lesions retain expression of a subset of disease-related genes Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis.Combined use of laser capture microdissection and cDNA microarray analysis identifies locally expressed disease-related genes in focal regions of psoriasis vulgaris skin lesions.Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis Update on psoriasis immunopathogenesis and targeted immunotherapy.Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis Gene profiling of narrowband UVB-induced skin injury defines cellular and molecular innate immune responses TREM-1 as a potential therapeutic target in psoriasis Current and potential immune therapies and vaccines in the management of psoriasis.The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.Harnessing dendritic cells in inflammatory skin diseases.FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.Skinomics: past, present and future for diagnostic microarray studies in dermatology.Apremilast for the treatment of psoriatic arthritis.Human dendritic cell functional specialization in steady-state and inflammation.Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin.IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.Generation and functional analysis of human TNF-α/iNOS-producing dendritic cells (Tip-DC).The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis.Systemic ALA-PDT effectively blocks the development of psoriasis-like lesions and alleviates leucocyte infiltration in the K14-VEGF transgenic mouse.Current knowledge on psoriasis and autoimmune diseases.Les cellules dendritiques inflammatoires

P2860

Q26751223-917800E9-CE7E-4C09-BC9B-E19633DFA87D Q26995800-6AF657C0-267F-4B8C-86A9-D0C09D959F10 Q27026785-73C56E2C-F051-4937-A815-7486839D3E3E Q27693878-559154C0-2F36-4E75-A3F1-6A9C3A911F20 Q28550785-4EEFC364-3EEC-4ACE-9C37-E14608DE53BD Q28732143-F0BA0650-B90E-4762-9594-A866FEBC0431 Q33565663-1A5B4E50-C243-4184-8758-45E3930C9C2D Q33878257-F1E4DE2B-0CDD-4523-B9BA-3A9913DEFF4A Q33969217-80FC4752-D1B3-4746-9761-F031BB07266B Q34180103-FC3BF315-795B-4B0A-9AAA-10F8FD0D5751 Q34200863-AD410D1C-B261-44C2-9B85-03B6A6B32EF3 Q34408063-B947912A-8A6E-429B-81A1-9C855175709A Q34490905-706E6A56-8B86-4405-B0F8-6C7068C6BBB7 Q35916032-6F9BBF92-E0F9-47A5-A816-821D405A1490 Q35962394-72ADAE08-A014-4AF5-A465-BED4A28706A8 Q36321202-6E7DD73A-4696-4876-AB20-817994FEAE8E Q36445919-671F696D-8752-4ECA-AF70-78B8C3B185C5 Q36754425-20D0ADB6-5572-49FF-AD9C-78DE223589BB Q36922025-AAE25B63-E238-4234-B582-F31A41ADC718 Q36972038-0CB4CE68-C47A-4BAA-90E3-D67F8FB44EC9 Q36977772-E8AF9AD4-D351-49BE-AC73-377A178D235D Q37040371-4FE33842-354A-4103-9585-97C10133A24F Q37673703-9A5A94E8-16BC-452E-8565-9E7C25B865F8 Q37709681-CE6BB13D-0904-483A-B22E-79A5F862229B Q37835969-44E62E58-3DBA-4C26-BFD8-E720EB39A7B3 Q38020837-1D30CF48-5185-4655-A6F3-D2F76A232C8D Q38061123-8C166C1E-9525-46E9-B817-15792F8A8D62 Q38154933-B8B70D8A-1159-4524-A410-305D65B02C47 Q38202205-D4114E80-EEC3-4FE6-845F-E34F56B3DF29 Q38205437-0F232ABE-9DDB-4A75-8F1D-1271CA88746E Q38885459-F0F95938-5E49-4F24-9041-E6CF35463DD1 Q41845458-ECBC2129-053F-42A8-BF08-6A7D10332246 Q41975379-BE04F4B0-6241-48D4-AB83-290C69A4C0DD Q45129672-57F30293-6654-45F9-B952-848919B1BF05 Q47754510-5489E1DC-FF8E-4525-A379-5060015EACD3 Q50593449-4B926AF9-7D88-4271-A498-761C783092FE Q55044800-1BBC9614-F160-4C12-8A70-18F1513D3F34 Q58861984-ABE8A3E0-2B50-44D2-8F71-15AE53757B73

P2860

Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.

http://www.wikidata.org/entity/Q34021856

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Identification of TNF-related ...... ls in patients with psoriasis.

@ast

Identification of TNF-related ...... ls in patients with psoriasis.

@en

Identification of TNF-related ...... ls in patients with psoriasis.

@nl

type

label

Identification of TNF-related ...... ls in patients with psoriasis.

@ast

Identification of TNF-related ...... ls in patients with psoriasis.

@en

Identification of TNF-related ...... ls in patients with psoriasis.

@nl

prefLabel

Identification of TNF-related ...... ls in patients with psoriasis.

@ast

Identification of TNF-related ...... ls in patients with psoriasis.

@en

Identification of TNF-related ...... ls in patients with psoriasis.

@nl

P1433

Q34021856-1CAA248C-0954-4E2A-BC0C-DCEF0AB6AA88

P1476

Q34021856-8506521F-8F08-4FBD-B427-EBA852B2D5E7

P2093

Q34021856-07098026-7C51-4881-8F06-DC070F778A3A

Q34021856-0BEEB588-1010-4642-8DB4-C9600A9BF6BC

Q34021856-0D2E18C5-A63B-4101-AC15-E43E58026249

Q34021856-4C533701-2DC1-412F-8482-EDF5E74DD54F

Q34021856-75B889F1-0EDF-4FBA-9EE1-2DB466D52322

Q34021856-937D18A9-3FC9-40F7-9BA4-683C88E8997F

Q34021856-B24FD8FF-21EB-447D-AB09-A88BCBDA901E

Q34021856-CBD10C2E-A510-49FB-9763-409F6DBA1FF5

Q34021856-CC1AAA3E-241C-43E8-A1B2-BDF17E082A1D

Q34021856-D968059A-AC88-493A-A727-B758F4246B89

P2860

Q34021856-00D0A347-4D58-4ADE-9A86-02AC96D54F13

Q34021856-0E96ADE9-A602-41FC-93AC-CA8891EA3C54

Q34021856-11C796EE-9023-447C-BA5F-8F8E6FE01539

Q34021856-11DA2996-5BBB-4AEF-841A-97AC36F0B2BF

Q34021856-1943BF54-A3F8-469C-BA01-F4A6C86908F3

Q34021856-1AF5AE60-08D6-42A6-8CEB-89060517A92F

Q34021856-21A50C6C-F0AA-43AC-B942-073C641E4B85

Q34021856-2AEF93E4-6482-4354-9799-71BC943CC5AA

Q34021856-353BBE7B-DB90-447D-A84B-FC392E2A131B

Q34021856-3DB51DF3-8B75-4394-A5E3-77E139C58D3E

P304

Q34021856-989297A1-7E82-4EDD-86F3-1BCABDCAC10D

P31

Q34021856-AB45888D-6DAB-40A5-A2FF-AF8775578031

P356

Q34021856-DA72A16F-D84D-48D2-815A-9D00EDE607D1

P407

Q34021856-042ED8DB-806C-4F28-B5A4-0CBC30C8F111

P433

Q34021856-37A29A29-5294-44E5-A01B-24C7D6B3D710

P478

Q34021856-9A7C0D4F-94DB-44F6-9852-C7EBEB3F9A00

P50

Q34021856-FCABD0F1-DF44-4EB1-B051-F8FB7E326C60

P577

Q34021856-F4F2C328-8CC8-4838-B776-5BEF50037B42

P5875

Q34021856-4CF777D4-DBC3-4682-A79E-BD69C381F828

P698

Q34021856-2362082E-720F-48D2-B59B-0A7185DC7F36

P921

Q34021856-10B12D6B-6463-4711-B458-3A8BE995F17B

P932

Q34021856-1D4BBEF2-0A6D-4822-B116-A3AF6BD40AF6

P356

J.JACI.2010.03.018

P1433

The Journal of Allergy and Clinical Immunology

P1476

Identification of TNF-related ...... ls in patients with psoriasis.

@en

P2093

James G Krueger

http://www.w3.org/2001/XMLSchema#string

Judilyn Fuentes-Duculan

http://www.w3.org/2001/XMLSchema#string

Katherine C Pierson

http://www.w3.org/2001/XMLSchema#string

Kristine E Nograles

http://www.w3.org/2001/XMLSchema#string

Leanne M Johnson-Huang

http://www.w3.org/2001/XMLSchema#string

Lisa C Zaba

http://www.w3.org/2001/XMLSchema#string

Mayte Suárez-Fariñas

http://www.w3.org/2001/XMLSchema#string

Narat John Eungdamrong

http://www.w3.org/2001/XMLSchema#string

Tim Lentini

http://www.w3.org/2001/XMLSchema#string

Traci R White

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

The receptor for the cytotoxic ligand TRAIL

Identification and characterization of a new member of the TNF family that induces apoptosis

Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions

Efalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindrance

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin.

Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

P304

1261-1268.e9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2010.03.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A Lowes

P577

2010-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44600298

http://www.w3.org/2001/XMLSchema#string

P698

20471070

http://www.w3.org/2001/XMLSchema#string

P921

P932

2910451

http://www.w3.org/2001/XMLSchema#string